Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Characterizing rare and low-frequency height-associated variants in the Japanese population.
|
31562340 |
2019 |
Cleft upper lip
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide meta-analyses of nonsyndromic orofacial clefts identify novel associations between FOXE1 and all orofacial clefts, and TP63 and cleft lip with or without cleft palate.
|
28054174 |
2017 |
Cleft Palate
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide meta-analyses of nonsyndromic orofacial clefts identify novel associations between FOXE1 and all orofacial clefts, and TP63 and cleft lip with or without cleft palate.
|
28054174 |
2017 |
Endometriosis
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
New variants near RHOJ and C2, HLA-DRA region and susceptibility to endometriosis in the Polish population-The genome-wide association study.
|
28881265 |
2017 |
Goldenhar Syndrome
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study identifies multiple susceptibility loci for craniofacial microsomia.
|
26853712 |
2016 |
Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
The DNA-binding protein AT-Rich Interactive Domain 3B (ARID3B) is elevated in ovarian cancer and increases tumor growth in a xenograft model of ovarian cancer.
|
26121572 |
2015 |
Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
To understand the extent that ARID3B participates in tumor development, we assessed protein expression of ARID3B in normal adult and malignant tissues.
|
24704276 |
2014 |
Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
To assess how ARID3B contributes to the increased tumor growth in vivo, we identified ARID3B induced genes in tumor ascites cells.
|
25327563 |
2014 |
Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
Nuclear ARID3B staining positively correlated with estrogen receptor (ER) status and negatively correlated with tumor grade, mitotic index and ERBB2 status of the patients.
|
25120063 |
2014 |
ovarian neoplasm
|
0.030 |
Biomarker
|
disease |
BEFREE |
The DNA-binding protein AT-Rich Interactive Domain 3B (ARID3B) is elevated in ovarian cancer and increases tumor growth in a xenograft model of ovarian cancer.
|
26121572 |
2015 |
ovarian neoplasm
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Recently we reported that the DNA binding protein ARID3B is overexpressed in human ovarian tumors.
|
25327563 |
2014 |
ovarian neoplasm
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
ARID3B is a DNA binding protein that is overexpressed in neuroblastoma and ovarian cancer.
|
24704276 |
2014 |
Schizophrenia
|
0.020 |
Biomarker
|
disease |
BEFREE |
These results suggest that SZ and BDP groups have different patterns of conflict adaptation.
|
30025790 |
2018 |
Schizophrenia
|
0.020 |
Biomarker
|
disease |
BEFREE |
We compared: (1) Psychosis Model (psychosis, non-psychosis), where the psychosis group included SZ, SA, and BDP+, and the non-psychosis group included BDP- and HC; (2) Schizophrenia Model (SZ, non-SZ); and (3) DSM Model (SZ, SA, BD, HC).
|
29768190 |
2018 |
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
These results highlight a chromatin-dependent mechanism where let-7 regulates cancer stemness through ARID3B.
|
26776511 |
2016 |
Primary malignant neoplasm
|
0.020 |
Biomarker
|
group |
BEFREE |
These results highlight a chromatin-dependent mechanism where let-7 regulates cancer stemness through ARID3B.
|
26776511 |
2016 |
Malignant neoplasm of ovary
|
0.020 |
Biomarker
|
disease |
BEFREE |
The DNA-binding protein AT-Rich Interactive Domain 3B (ARID3B) is elevated in ovarian cancer and increases tumor growth in a xenograft model of ovarian cancer.
|
26121572 |
2015 |
Carcinoma, Ovarian Epithelial
|
0.020 |
Biomarker
|
disease |
BEFREE |
The DNA-binding protein AT-Rich Interactive Domain 3B (ARID3B) is elevated in ovarian cancer and increases tumor growth in a xenograft model of ovarian cancer.
|
26121572 |
2015 |
Malignant neoplasm of breast
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Increased nuclear expression of ARID3B was confirmed in breast cancer-derived cell lines expressing ERα.
|
25120063 |
2014 |
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Moreover, ARID3B increased the number of CD133+ (a cancer stem cell marker) cells compared to control cells.
|
25327563 |
2014 |
Neuroblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
ARID3B is a DNA binding protein that is overexpressed in neuroblastoma and ovarian cancer.
|
24704276 |
2014 |
Breast Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Increased nuclear expression of ARID3B was confirmed in breast cancer-derived cell lines expressing ERα.
|
25120063 |
2014 |
Central neuroblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
ARID3B is a DNA binding protein that is overexpressed in neuroblastoma and ovarian cancer.
|
24704276 |
2014 |
Malignant neoplasm of ovary
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
ARID3B is a DNA binding protein that is overexpressed in neuroblastoma and ovarian cancer.
|
24704276 |
2014 |
Primary malignant neoplasm
|
0.020 |
Biomarker
|
group |
BEFREE |
Moreover, ARID3B increased the number of CD133+ (a cancer stem cell marker) cells compared to control cells.
|
25327563 |
2014 |